Dr. Daw studies how policies affect the barriers faced by populations in accessing needed health services, from gaining health insurance to connecting with providers and ultimately, recieving high-quality care. Her recent work focuses on the impact of state and federal policies on access to care for women and families in the period surrounding childbirth. Dr. Daw also studies prescription drug coverage policy and access to medicines in the U.S., Canada, and other developed countries. Her work has been published in leading medical, health services, and policy research journals including JAMA, CMAJ, Obstetrics & Gynecology, Health Affairs, and the Journal of Health Policy, Politics and Law.
PhD, 2018, Harvard University
MSc, 2010, University of British Columbia
BSc, 2004, McMaster University
Areas of Expertise
Research Design and Methods, Women's Health, Healthcare Financing, Healthcare Policy, Medicaid/Medicare, Uninsured, Maternal Health, Prenatal/Perinatal Care
Daw JR, Hatfield LA. Matching and regression to the mean in difference-in-differences analysis. Health Services Research: Early View. 2018.
Daw JR, Sommers BD. Association of the Affordable Care Act dependent coverage provision with prenatal care use and birth outcomes. JAMA: 319(6). 579-587, 2018.
Daw JR, Sommers BD. Pregnancy, immigration, and health insurance: new evidence and ongoing debate. Obstetrics & Gynecology: 130(5). 935-937, 2017.
Daw JR, Hatfield LA, Swartz K, Sommers BD. Women in the United States experience high rates of insurance coverage ‘churn’ in months before and after childbirth. Health Affairs: 36(4). 598-606, 2017.
Morgan SG, Law MR, Daw JR, Abraham L, Martin D. Estimated cost of universal public coverage of prescription drugs in Canada. Canadian Medical Association Journal: 187. 491-497, 2015.
Daw JR, Morgan SG, Collins PA, Abelson J. Framing incremental expansions to public health insurance programs: the case of Canadian pharmacare. Journal of Health Politics, Policy, and Law: 39(2). 295-330, 2014.
Morgan SG, Daw JR, Thomson PA. International best practices for negotiating ‘reimbursement contracts’ with price rebates from pharmaceutical companies. Health Affairs: 32(4). 771-777., 2013.
Law MR, Daw JR, Cheng L, Morgan SG. Growth in private payments for health care by Canadian households. Health Policy: 110(2). 141-146, 2013.
Daw JR, Morgan SG. 2012. Stitching the gaps in the Canadian public drug coverage patchwork? A review of provincial pharmacare policy changes 2000-2010. Health Policy: 104(1). 19-26, 2012.
Daw JR, Hanley GE, Greyson DG, Morgan SG. 2011. Prescription drug use during pregnancy in developed countries: a systematic review. Pharmacoepidemiology and Drug Safety: 20(9). 895-902, 2011